These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9108417)

  • 1. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
    Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
    Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
    Inagaki N; Asaoka D; Mori KL; Sohda N; Miura I; Miwa H; Sato N; Oshimi K
    Leuk Lymphoma; 2004 Jul; 45(7):1471-4. PubMed ID: 15359651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.
    Emile JF; Boulland ML; Haioun C; Kanavaros P; Petrella T; Delfau-Larue MH; Bensussan A; Farcet JP; Gaulard P
    Blood; 1996 Feb; 87(4):1466-73. PubMed ID: 8608237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
    Chiang AK; Chan AC; Srivastava G; Ho FC
    Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal multiple involvement of enteropathy-type T-cell lymphoma without expression of CC chemokine receptor 7.
    Shiratsuchi M; Suehiro Y; Yoshikawa Y; Ohshima K; Shiokawa S; Nishimura J
    Int J Hematol; 2004 Jan; 79(1):44-7. PubMed ID: 14979477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.
    Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y
    Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.
    Kameoka J; Ichinohasama R; Tanaka M; Miura I; Tomiya Y; Takahashi S; Yamada M; Ishikawa I; Kadowaki I; Sasaki O; Kimura J; Meguro K; Ooya K; Ito S
    Am J Clin Pathol; 1998 Oct; 110(4):478-88. PubMed ID: 9763034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD56- and CD4-positive non-Hodgkin's lymphoma of probable T-cell origin].
    Honda S; Ito Y; Otawa M; Katagiri T; Kuriyama Y; Serizawa H; Ebihara Y; Mukai K; Ohyashiki K
    Rinsho Ketsueki; 2001 May; 42(5):420-5. PubMed ID: 11452463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
    Kaplan LD; Shiramizu B; Herndier B; Hahn J; Meeker TC; Ng V; Volberding PA; McGrath MS
    Blood; 1995 Apr; 85(7):1727-35. PubMed ID: 7535586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer-like T-cell lymphoma of the parotid in a patient infected with human immunodeficiency virus.
    Cornfield DB; Papiez JS; Lynch JT; Rimsza LM
    Arch Pathol Lab Med; 2002 Jun; 126(6):738-41. PubMed ID: 12033970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
    Zhang B; Zong Y; He J; Zhong B; Lin S
    Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
    Lan MX; Zhen ZX; Ming WH
    Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
    Tsujimura H; Takagi T; Tamaru J; Sakai C
    Leuk Lymphoma; 2000 May; 37(5-6):633-4. PubMed ID: 11042526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
    Schleiffenbaum B; Rüegg R; Zimmermann D; Fehr J
    Am J Hematol; 1995 Jul; 49(3):221-31. PubMed ID: 7541603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission.
    Shimizu K; Hara K; Yatabe Y
    Int J Hematol; 1999 Feb; 69(2):96-100. PubMed ID: 10071458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
    Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.